Unit
Muskelzentrum | ALS Clinic
MUSKEL · Dept. III
Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene
Czell D, Andersen P, Neuwirth C, Morita M, Weber M. Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14:138-40.
Jan 3, 2013Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene
Jan 3, 2013Amyotroph Lateral Scler Frontotemporal Degener 2013; 14:138-40
Czell David, Andersen Peter M, Neuwirth Christoph, Morita Mitsuya, Weber Markus
Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation
Czell D, Abicht A, Hench J, Weber M. Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation. BMJ Case Rep 2012; 2012
Dec 6, 2012Exercise-induced myalgia and rhabdomyolysis in a patient with the rare m.3243A>T mtDNA mutation
Dec 6, 2012BMJ Case Rep 2012; 2012
Czell David, Abicht Angela, Hench Jürgen, Weber Markus
[The head-up-orthosis - a good solution for ambulant patients with Dropped-head-syndrome]
Czell D, Weber M. [The head-up-orthosis - a good solution for ambulant patients with Dropped-head-syndrome]. Praxis (Bern 1994) 2012; 101:1499-502.
Nov 14, 2012[The head-up-orthosis - a good solution for ambulant patients with Dropped-head-syndrome]
Nov 14, 2012Praxis (Bern 1994) 2012; 101:1499-502
Czell D, Weber Markus
Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation
Czell D, Bauer M, Binek J, Schoch O, Weber M. Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation. Respir Care 2012
Oct 26, 2012Outcome of Percutaneous Endoscopic Gastrostomy Tube Insertion in Respiratory Impaired Amyotrophic Lateral Sclerosis Patients Under Non-Invasive Ventilation
Oct 26, 2012Respir Care 2012
Czell David, Bauer Matthias, Binek Janek, Schoch Otto, Weber Markus
Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers
Stutzki R, Schneider U, Reiter-Theil S, Weber M. Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers. Front Psychol 2012; 3:443.
Oct 25, 2012Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers
Oct 25, 2012Front Psychol 2012; 3:443
Stutzki Ralf, Schneider Ursula, Reiter-Theil Stella, Weber Markus
H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis
van Rheenen W, de Visser M, Weber M, Robberecht W, Hardiman O, Shaw P, Shaw C, Morrison K, Al-Chalabi A, Andersen P, Ludolph A, Veldink J, van der Kooi A, Schelhaas H, Waibel S, Diekstra F, van Doormaal P, Seelen M, Kenna K, McLaughlin R, Shatunov A, Czell D, van Es M, van Vught P, Van Damme P, Smith B, van den Berg L. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging 2012; 34:1517.e5-7.
Oct 11, 2012H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis
Oct 11, 2012Neurobiol Aging 2012; 34:1517.e5-7
van Rheenen Wouter, de Visser Marianne, Weber Markus, Robberecht Wim, Hardiman Orla, Shaw Pamela J, Shaw Christopher E, Morrison Karen E, Al-Chalabi Ammar, Andersen Peter M, Ludolph Albert C, Veldink Jan H, van der Kooi Anneke J, Schelhaas H Jurgen, Waibel Stefan, Diekstra Frank P, van Doormaal Perry T C, Seelen Meinie, Kenna Kevin, McLaughlin Russell, Shatunov Aleksey, Czell David, van Es Michael A, van Vught Paul W J, Van Damme Philip, Smith Bradley N, van den Berg Leonard H
Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial
Bauer M, Czell D, Hartmann S, Goldman B, Müller D, Weber M. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial. Respiration 2012; 84:306-11.
Jul 28, 2012Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial
Jul 28, 2012Respiration 2012; 84:306-11
Bauer M, Czell David, Hartmann S, Goldman B, Müller D, Weber Markus
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder
Shaw C, Shaw P, Robberecht W, Van Damme P, Veldink J, Van den Berg L, Ticozzi N, Taroni F, Gellera C, Silani V, Kirby J, Pall H, Morrison K, Al-Chalabi A, Weale M, Brown R, Landers J, Andersen P, Baas F, Vianney de Jong J, de Belleroche J, Morris A, Asbroek A, Schelhaas H, Scott K, Troakes C, Lee Y, Miller J, Johnson L, Topp S, Vance C, Shatunov A, Newhouse S, Jones A, Gray I, Wright J, Nestor P, Weber M, Sapp P, Lovestone S, Lupton M, Powell J, Rogelj B, Al-Sarraj S, Hortobágyi T, Smith B. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet 2012; 21:102-8.
Jun 13, 2012The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder
Jun 13, 2012Eur J Hum Genet 2012; 21:102-8
Shaw Christopher E, Shaw Pamela J, Robberecht Wim, Van Damme Phillip, Veldink Jan, Van den Berg Leonard, Ticozzi Nicola, Taroni Franco, Gellera Cinzia, Silani Vincenzo, Kirby Janine, Pall Hardev, Morrison Karen E, Al-Chalabi Ammar, Weale Michael E, Brown Robert H, Landers John, Andersen Peter M, Baas Frank, Vianney de Jong J M B, de Belleroche Jacqueline, Morris Alex, Asbroek Anneloor Alm Ten, Schelhaas Helenius J, Scott Kirsten M, Troakes Claire, Lee Younbok, Miller Jack, Johnson Lauren, Topp Simon, Vance Caroline, Shatunov Aleksey, Newhouse Stephen, Jones Ashley, Gray Ian, Wright Jamie, Nestor Peter J, Weber Markus, Sapp Peter C, Lovestone Simon, Lupton Michelle, Powell John, Rogelj Boris, Al-Sarraj Safa, Hortobágyi Tibor, Smith Bradley N
Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
Jörger M, Wilkins J, Fagagnini S, Baldinger R, Brenneisen R, Schneider U, Goldman B, Weber M. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis. Drug Metab Lett 2012; 6:102-8.
Jun 1, 2012Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
Jun 1, 2012Drug Metab Lett 2012; 6:102-8
Jörger Markus, Wilkins Justin, Fagagnini Stefania, Baldinger Reto, Brenneisen Rudolf, Schneider Ursula, Goldman Bea, Weber Markus
Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
Baldinger R, Katzberg H, Weber M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012; 4:CD004157.
Apr 18, 2012Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
Apr 18, 2012Cochrane Database Syst Rev 2012; 4:CD004157
Baldinger Reto, Katzberg Hans Dieter, Weber Markus
[Sensory neuronopathy of Sjögren's syndrome : A diagnostic challenge]
Czell D, Baldinger R, Jochum W, Weber M. [Sensory neuronopathy of Sjögren's syndrome : A diagnostic challenge]. Nervenarzt 2012; 83:226-35.
Feb 1, 2012[Sensory neuronopathy of Sjögren's syndrome : A diagnostic challenge]
Feb 1, 2012Nervenarzt 2012; 83:226-35
Czell David, Baldinger R, Jochum Wolfram, Weber Markus
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study
Häuptle R, Weilenmann D, Schneider T, Haile S, Ammann P, Knellwolf C, Borovicka J. Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study. Wien Med Wochenschr 2012; 162:67-73.
Feb 1, 2012Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study
Feb 1, 2012Wien Med Wochenschr 2012; 162:67-73
Häuptle Rahel, Weilenmann Daniel, Schneider Tino, Haile Sarah, Ammann Peter, Knellwolf Christina, Borovicka Jan
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
van den Berg L, Heutink P, van Hilten J, Verbaan D, de Visser M, van der Kooi A, Weber M, Klein C, Waibel S, Fernández-Santiago R, Birve A, Dahlberg C, Lemmens R, Hennekam E, Cuppen E, van de Warrenburg B, Landers J, de Bakker P, Pasterkamp R, Veldink J, Ophoff R, Robberecht W, Ludolph A, Gasser T, Silani V, Brown R, Berg D, Van Damme P, Pezzoli G, Keagle P, LeClerc A, Fumoto K, Diekstra F, Koppers M, Blauw H, Schulte C, Groen E, Andersen P, Ticozzi N, van Vught P, Schelhaas H, Bloem B, Scheffer H, Goldwurm S, Mariani C, Folkerth R, Wu D, Kishikawa H, Yu W, Hu G, Lowe P, Wills A, van Rheenen W, van Blitterswijk M, van Nuenen B, van Es M. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 2011; 70:964-73.
Dec 1, 2011Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
Dec 1, 2011Ann Neurol 2011; 70:964-73
van den Berg Leonard H, Heutink Peter, van Hilten Jacobus J, Verbaan Dagmar, de Visser Marianne, van der Kooi Anneke J, Weber Markus, Klein Christine, Waibel Stefan, Fernández-Santiago Rubén, Birve Anna, Dahlberg Caroline, Lemmens Robin, Hennekam Eric A M, Cuppen Edwin, van de Warrenburg Bart P, Landers John E, de Bakker Paul I W, Pasterkamp R Jeroen, Veldink Jan H, Ophoff Roel A, Robberecht Wim, Ludolph Albert C, Gasser Thomas, Silani Vincenzo, Brown Robert H, Berg Daniela, Van Damme Philip, Pezzoli Gianni, Keagle Pamela, LeClerc Ashley Lyn, Fumoto Katsumi, Diekstra Frank P, Koppers Max, Blauw Hylke M, Schulte Claudia, Groen Ewout J N, Andersen Peter M, Ticozzi Nicola, van Vught Paul W J, Schelhaas Helenius J, Bloem Bastiaan R, Scheffer Hans, Goldwurm Stefano, Mariani Claudio, Folkerth Rebecca D, Wu David, Kishikawa Hiroko, Yu Wenhao, Hu Guo-fu, Lowe Patrick P, Wills Anne-Marie, van Rheenen Wouter, van Blitterswijk Marka, van Nuenen Bart F L, van Es Michael A
Weniger alltägliche Bauchschmerzen
Kreiner A, Neuwirth C, Bilz S. Weniger alltägliche Bauchschmerzen. Schweiz Med Forum 2011; 11:85-96.
Nov 15, 2011Weniger alltägliche Bauchschmerzen
Nov 15, 2011Schweiz Med Forum 2011; 11:85-96
Kreiner Annika, Neuwirth Christoph, Bilz Stefan
Diagnose und Therapie? - Frag den Patienten!
Czell D. Diagnose und Therapie? - Frag den Patienten!. Aktuelle Neurologie 2011; Epub [ahead of print]
Nov 7, 2011Diagnose und Therapie? - Frag den Patienten!
Nov 7, 2011Aktuelle Neurologie 2011; Epub [ahead of print]
Czell David
Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats
Czell D, Efe T, Preuss M, Schofer M, Becker R. Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats. Neurochem Res 2011; 37:381-6.
Oct 9, 2011Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats
Oct 9, 2011Neurochem Res 2011; 37:381-6
Czell David, Efe Turgay, Preuss Matthias, Schofer Markus D, Becker Ralf
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Wasner M, Tomik B, Silani V, Pradat P, Petri S, Morrison K, Kollewe K, Hardiman O, Van Damme P, Chio A, de Carvalho M, Borasio G, Abrahams S, Andersen P, Weber M. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 2011; 19:360-75.
Sep 14, 2011EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force
Sep 14, 2011Eur J Neurol 2011; 19:360-75
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Wasner Maria, Tomik Barbara, Silani Vincenzo, Pradat Pierre-Francois, Petri Susanne, Morrison Karen E, Kollewe Katja, Hardiman Orla, Van Damme Philip, Chio Adriano, de Carvalho Mamede, Borasio Gian D, Abrahams Sharon, Andersen Peter M, Weber Markus
Motor Unit Number Index (MUNIX): reference values of five different muscles in healthy subjects from a multi-centre study
Neuwirth C, Sandberg A, Otto M, Costa J, Castro J, Baldinger R, van Dijk J, Furtula J, Carvalho M, Barkhaus P, Stålberg E, Nandedkar S, Weber M. Motor Unit Number Index (MUNIX): reference values of five different muscles in healthy subjects from a multi-centre study. Clin Neurophysiol 2011; 122:1895-8.
Sep 1, 2011Motor Unit Number Index (MUNIX): reference values of five different muscles in healthy subjects from a multi-centre study
Sep 1, 2011Clin Neurophysiol 2011; 122:1895-8
Neuwirth Christoph, Sandberg Arne, Otto Marit, Costa João, Castro José, Baldinger Reto, van Dijk Johannes P, Furtula Jasna, Carvalho Mamede de, Barkhaus Paul E, Stålberg Erik, Nandedkar Sanjeev, Weber Markus
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect
Gispert S, Ludolph A, Riess O, Krüger R, Andersen P, Berg D, Weber M, Becker T, Gitler A, Geisen C, Liepelt I, Bauer P, Waibel S, Kurz A, Auburger G. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 2011; 45:356-61.
Aug 25, 2011The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect
Aug 25, 2011Neurobiol Dis 2011; 45:356-61
Gispert Suzana, Ludolph Albert C, Riess Olaf, Krüger Rejko, Andersen Peter M, Berg Daniela, Weber Markus, Becker Tim, Gitler Aaron D, Geisen Christof, Liepelt Inga, Bauer Peter, Waibel Stefan, Kurz Alexander, Auburger Georg
ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival
Weber M, Marklund S, Birve A, Jung H, Petersen J, Czaplinski A, Schweikert K, Thierbach J, Neuwirth C, Andersen P. ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival. J Neurol Neurosurg Psychiatr 2011; 83:351-3.
Jun 23, 2011ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival
Jun 23, 2011J Neurol Neurosurg Psychiatr 2011; 83:351-3
Weber Markus, Marklund S L, Birve A, Jung H H, Petersen J, Czaplinski A, Schweikert K, Thierbach J, Neuwirth Christoph, Andersen P M